Table 3.
Log-transformed | COX PROPORTIONAL HAZARD
|
|||||
---|---|---|---|---|---|---|
UNADJUSTED | MODEL 1§ | MODEL 2¶ | ||||
Hazard Ratio# | P-value | Hazard Ratio# | P-value | Hazard Ratio# | P-value | |
Urea | 1.40 (1.22–1.59) | <0.0001 | 1.25 (1.09–1.42) | 0.0016 | 1.14 (0.96–1.28) | 0.17 |
Creatinine | 1.34 (1.21–1.48) | <0.0001 | 1.22 (1.09–1.35) | 0.0008 | 1.17 (1.03–1.32) | 0.015 |
eGFRMDRD | 0.72 (0.65–0.80) | <0.0001 | 0.80 (0.72–0.90) | 0.0002 | 0.85 (0.75–0.96) | 0.012 |
Cystatin C | 1.45 (1.30–1.60) | <0.0001 | 1.29 (1.15–1.44) | <0.0001 | 1.20 (1.05–1.36) | 0.0085 |
eGFRCysC | 0.69 (0.62–0.77) | <0.0001 | 0.77 (0.68–0.87) | <0.0001 | 0.82 (0.73–0.94) | 0.006 |
eGFRsCr+CysC | 0.70 (0.63–0.78) | <0.0001 | 0.78 (0.70–0.88) | <0.0001 | 0.83 (0.73–0.94) | 0.006 |
Abbreviations as in Table 1. P-value for log(BNP) <0.001 in every model.
Model 1 is adjusted for log-transformed BNP
Model 2 is further adjusted for age, BMI, history of coronary artery disease, history of diabetes mellitus, hemoglobin, and hsCRP.
Hazard ratios are per 1-standard deviation (Urea 12.7, Creatinine 0.89, eGFRMDRD 26.2, Cystatin C 0.73, eGFRCysC 23.7, eGFRsCr+CysC 24.8)